Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · IEX Real-Time Price · USD
404.15
+0.88 (0.22%)
At close: Mar 28, 2024, 4:00 PM
411.90
+7.75 (1.92%)
After-hours: Mar 28, 2024, 7:47 PM EDT
Medpace Holdings Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Medpace Holdings stock have an average target of 389, with a low estimate of 273 and a high estimate of 480. The average target predicts a decrease of -3.75% from the current stock price of 404.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MEDP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 0 | 0 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 2 | 3 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Deutsche Bank | Deutsche Bank | Hold Initiates $395 | Hold | Initiates | $395 | -2.26% | Mar 18, 2024 |
UBS | UBS | Strong Buy Maintains $452 → $480 | Strong Buy | Maintains | $452 → $480 | +18.77% | Mar 8, 2024 |
UBS | UBS | Hold → Strong Buy Upgrades $282 → $452 | Hold → Strong Buy | Upgrades | $282 → $452 | +11.84% | Feb 15, 2024 |
Baird | Baird | Buy Maintains $312 → $408 | Buy | Maintains | $312 → $408 | +0.95% | Feb 14, 2024 |
Baird | Baird | Buy Maintains $302 → $312 | Buy | Maintains | $302 → $312 | -22.80% | Jan 17, 2024 |
Financial Forecast
Revenue This Year
2.23B
from 1.89B
Increased by 18.30%
Revenue Next Year
2.60B
from 2.23B
Increased by 16.49%
EPS This Year
10.86
from 8.88
Increased by 22.35%
EPS Next Year
12.92
from 10.86
Increased by 18.95%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.3B | 2.8B | 3.3B | 3.4B | 3.6B |
Avg | 2.2B | 2.6B | 3.0B | 3.2B | 3.5B |
Low | 2.1B | 2.4B | 2.7B | 3.1B | 3.4B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 22.6% | 24.2% | 28.4% | 13.4% | 11.5% |
Avg | 18.3% | 16.5% | 15.6% | 8.0% | 8.3% |
Low | 13.2% | 8.8% | 4.8% | 1.7% | 4.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.36 | 13.59 | 16.86 | 19.03 | 18.14 |
Avg | 10.86 | 12.92 | 15.31 | 17.02 | 17.63 |
Low | 10.34 | 11.73 | 13.44 | 14.95 | 16.93 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.9% | 25.1% | 30.5% | 24.3% | 6.6% |
Avg | 22.4% | 18.9% | 18.4% | 11.2% | 3.5% |
Low | 16.4% | 8.0% | 4.0% | -2.3% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.